Doing Business in Japan -BioMedical Cluster, Kobe -
Japan, the second biggest medical device market in the world, is a promising highly profitable market for foreign companies. It's main attractions of being a highly stable and steady growth market have in recent years been accelerated by deregulations. Within this market, Kobe City, well-known for creating many advanced technologies and research results in collaboration with government-industry-academia, has built the best biomedical cluster in Japan. In this seminar, the Mayor of Kobe City will introduce the lucrative business environment and highly regarded special incentives. In conjunction, Eli Lilly Japan K. K., subsidiary of U.S. pharmaceutical – Eil Lilly and Company, has had an immense amount of success in Japan, and they will share their success and how Kobe City enabled them as a global organization.
Date & Time: Tuesday, June 16, 2015 3:30 – 5:10pm
Location:Nikko Grand Ballroom 3F, Hotel Nikko San Francisco
Organized by:Kobe City, Japan
Co-organized by:JETRO San Francisco
Supported by:Consulate-General of Japan in San Francisco
Jun Yamada, Consul General, Consulate-General of Japan in San Francisco(tentative)
3:30 Abenomics and Investment Enviroment in Japan (tentative)
Yoshiaki Tojo, Chief Excutive Director, JETRO San Francisco
4:00 Keynote Speech - Investment Climate in Kobe
Kizo Hisamoto, Mayor of Kobe
4:25 Keynote Speech - Expansion into Kobe and Business Development in Japan
Akikazu Yoshikawa, Operating Officer, Senior Director, Science & Regulatory Affairs, Eli Lilly Japan, K.K.
4:50 Q & A
5:10 Closing Remarks